瑞風新能源(00527.HK)折讓約16.67%配售最多1.8億股 淨籌4400萬港元
格隆匯12月4日丨瑞風新能源(00527.HK)公佈,於12月4日,公司與獨家配售代理訂立配售協議,據此,獨家配售代理促使不少於六名承配人按配售價每股配售股份0.25港元認購最多1.8億股配售股份。
公告顯示,1.8億股配售股份佔(i)公司現時已發行股本約10.00%;及(ii)公司經擴大股本約9.09%。配售價較收市價每股股份0.30港元折讓約16.67%。
此外,配售事項的所得款項總額及所得款項淨額將分別約為4500萬港元及4400萬港元,該等金額將用作償還集團部分流動借貸,並將擴大公司的股東基礎,從而可提高股份的流通性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.